References
1. Khor, B., A. Gardet, and R. Xavier, Genetics and pathogenesis of inflammatory bowel disease. Nature, 2011. 474: p. 307-317.
2. Ahuja, V. and R.K. Tandon, Inflammatory bowel disease in the Asia–Pacific area: A comparison with developed countries and regional differences. Journal of Digestive Diseases, 2010. 11.
3. Lee, Y.M., K. Fock, S.J. See, T.M. Ng, and E.K. Teo, Racial difference in the prevalence of ulcerative colitis and Crohn’s disease in Singapore. Journal of Gastroenterology & Hepatology, 2000. 15(6): p. 622-625.
4. Zheng, J., Ju, S.Z. Xia, H. Zhao, H.S. Xiao, and R.G. Zhi,Prevalence and incidence rates of Crohn’s disease in mainland China: A meta-analysis of 55 years of research. Journal of Digestive Diseases, 2010. 11(3): p. 161-166.
5. Wilson, M.J., M. Torkar, A. Haude, S. Milne, T. Jones, D. Sheer, S. Beck, and J. Trowsdale, Plasticity in the organization and sequences of human KIR/ILT gene families. Proceedings of the National Academy of Sciences of the United States of America, 2000. 97(9): p. 4778-4783.
6. Armin, V., W. Hagen, L. Katja, and Z. Andreas, Genesis of the ILT/LIR/MIR clusters within the human leukocyte receptor complex&nbsp.Immunological Reviews, 2002. 181(1): p. 39-51.
7. Barten, R., M. Torkar, A. Haude, J. Trowsdale, and M.J. Wilson,Divergent and convergent evolution of NK-cell receptors. Trends in Immunology, 2001. 22(1): p. 52-57.
8. Torkar, M., A. Haude, S. Milne, S. Beck, and M.J. Wilson,Arrangement of the ILT gene cluster: A common null allele of the ILT6 gene results from a 6.7-Kbp deletion. European Journal of Immunology, 2001. 30(12): p. 3655-3662.
9. Torkar, M., Z. Norgate, M. Colonna, J. Trowsdale, and M.J. Wilson,Isotypic variation of novel immunoglobulin-like transcript/killer cell inhibitory receptor loci in the leukocyte receptor complex.European Journal of Immunology, 1998. 28(12): p. 3959-3967.
10. Kabalak, G., S. Koch, B. Dobberstein, Y.H. The, T. Matthias, S. Schnarr, R.E. Schmidt, and T. Witte, Immunoglobulin-like Transcripts as Risk Genes for Autoimmunity. Ann N Y Acad Sci, 2007. 1110(Autoimmunity Part B Novel Applications of Basic Research): p. 10-14.
11. Kabalak, G., S.B. Dobberstein, T. Matthias, S. Reuter, and T. Witte,Association of immunoglobulin-like transcript 6 deficiency with Sjögren’s syndrome. Arthritis Rheum, 2009. 60(10): p. 2923-2925.
12. Ordó?Ez, D., A.J. Sánchez, J.E. Martínez-Rodríguez, E. Cisneros, E. Ramil, N. Romo, M. Moraru, E. Munteis, M. López-Botet, et al.,Multiple sclerosis associates with LILRA3 deletion in Spanish patients. Genes & Immunity, 2009. 10(6): p. 579-585.
13. Du, Y., Y. Cui, X. Liu, F. Hu, and Z. Li, Contribution of Functional LILRA3, but Not Nonfunctional LILRA3, to Sex Bias in Susceptibility and Severity of Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis. Arthritis & Rheumatology, 2014. 66(4): p. 822-830.
14. Koch, S., R. Goedde, V. Nigmatova, J.T. Epplen, N. Müller, J. de Seze, P. Vermersch, T. Momot, R.E. Schmidt, et al., Association of multiple sclerosis with ILT6 deficiency. Genes & Immunity, 2005. 6(5): p. 445-447.
15. Yang, J., W. Li, G. Xin, T. Sha, T. Lu, N. Rong, C. Zhuo, K. Jian, Z. Siqun L, et al., LILRA3 Is Associated with Benign Prostatic Hyperplasia Risk in a Chinese Population. International Journal of Molecular Sciences, 2013. 14(5): p. 8832-8840.
16. Xu, J., Z. Mo, D. Ye, M. Wang, F. Liu, G. Jin, C. Xu, X. Wang, Q. Shao, et al., Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.Nature Genetics, 2012. 44(11): p. 1231-1235.
17. Tedla, N., H. An, L. Borges, U. Vollmer-Conna, K. Bryant, C. Geczy, and H.P. McNeil, Expression of activating and inhibitory leukocyte immunoglobulin-like receptors in rheumatoid synovium: correlations to disease activity. Tissue Antigens, 2011. 77(4): p. 305-316.
18. Du, Y., Y. Su, J. He, Y. Yang, and Z. Li, Impact of the leucocyte immunoglobulin-like receptor A3 (LILRA3) on susceptibility and subphenotypes of systemic lupus erythematosus and Sjogren’s syndrome.Annals of the Rheumatic Diseases, 2014. 74(11): p. 2070-2075.
19. An, H., L. Chai, G.G. J., V.-C. Ute, R. William, B. Katherine, T. Nicodemus, and N. Serge, Serum Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3) Is Increased in Patients with Multiple Sclerosis and Is a Strong Independent Indicator of Disease Severity; 6.7kbp LILRA3 Gene Deletion Is Not Associated with Diseases Susceptibility. Plos One, 2016. 11(2): p. e0149200-.
20. An, H., V. Chandra, B. Piraino, L. Borges, C. Geczy, H.P. Mcneil, K. Bryant, and N. Tedla, Soluble LILRA3, a potential natural antiinflammatory protein, is increased in patients with rheumatoid arthritis and is tightly regulated by interleukin 10, tumor necrosis factor-alpha, and interferon-gamma. Journal of Rheumatology, 2010. 37(8): p. 1596-1606.
21. Zhi, L.H., R. Sandra, T. Michael, D. Nadine, P. Dietrich, K. Gamze, S. Renata, S.R. E., M. Torsten, et al., Association of the LILRA3 Deletion with B-NHL and Functional Characterization of the Immunostimulatory Molecule. Plos One, 2013. 8(12): p. e81360.
22. An, H., M. Brettle, T. Lee, B. Heng, C.K. Lim, G.J. Guillemin, M.S. Lord, E. Klotzsch, C.L. Geczy, et al., Soluble LILRA3 promotes neurite outgrowth and synapses formation through high affinity interaction with Nogo 66. Journal of Cell Science, 2016: p. jcs.182006.
23. Lee, T.H.Y., A. Mitchell, S. Liu Lau, H. An, P. Rajeaskariah, V. Wasinger, M. Raftery, K. Bryant, and N. Tedla, Glycosylation in a Mammalian Expression System Is Critical for the Production of Functionally Active Leukocyte Immunoglobulin-like Receptor A3 Protein.Journal of Biological Chemistry, 2013. 288(46): p. 32873-32885.
24. Brown, D., J. Trowsdale, and R. Allen, The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens, 2004. 64: p. 215-225.
25. Kane, B.A., K.J. Bryant, H.P. McNeil, and N.T. Tedla,Termination of Immune Activation: An Essential Component of Healthy Host Immune Responses. Journal of Innate Immunity, 2014. 6(6): p. 727-738.
26. Geissmann, F., M.G. Manz, S. Jung, M.H. Sieweke, M. Merad, and K. Ley, Development of Monocytes, Macrophages, and Dendritic Cells.2010. 327(5966): p. 656-661.
27. Auffray, C., M.H. Sieweke, and F. Geissmann, Blood Monocytes: Development, Heterogeneity, and Relationship with Dendritic Cells.Annual Review of Immunology, 2009. 27(1): p. 669-692.
28. Liu, C., X. Xu, and Y. Zhou, Association between EGFR polymorphisms and the risk of lung cancer. International Journal of Clinical & Experimental Pathology, 2015. 8(11): p. 15245-15249.
29. Liang, J., T. Zhao, J. Yang, W. Li, F. Zhang, S. Zhang, Z. Huang, R. Lin, and X. Zhang, MMP-9 gene polymorphisms (rs3918242, rs3918254 and rs4810482) and the risk of psoriasis vulgaris: No evidence for associations in a Chinese Han population. Immunology Letters, 2015. 168(2): p. 343-348.
30. Hirayasu, K., J. Ohashi, H. Tanaka, K. Kashiwase, A. Ogawa, M. Takanashi, M. Satake, G.J. Jia, N.-O. Chimge, et al., Evidence for Natural Selection on Leukocyte Immunoglobulin-like Receptors for HLA Class I in Northeast Asians. The American Journal of Human Genetics, 2008. 82(5): p. 1075-1083.
31. Murphy, J.E., P.R. Tedbury, S. Homer-Vanniasinkam, J.H. Walker, and S. Ponnambalam, Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis, 2005. 182(1): p. 1-15.
32. Martinez‐Pomares, L., The mannose receptor. Journal of Leukocyte Biology, 2012. 92.
33. Jones, D.C.D., V.V. Kosmoliaptsis, R.R. Apps, N.N. Lapaque, I.I. Smith, A.A. Kono, C.C. Chang, L.H.L. Boyle, C.J.C. Taylor, et al.,HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding. Journal of immunology, 2011. 186(5): p. 2990.
34. Shiroishi, M., K. Tsumoto, K. Amano, Y. Shirakihara, M. Colonna, V.M. Braud, D.S.J. Allan, A. Makadzange, S. Rowland-Jones, et al.,Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proceedings of the National Academy of Sciences of the United States of America, 2003. 100(15): p. 8856-8861.
35. Jones, D.C., A. Roghanian, D.P. Brown, C. Chang, R.L. Allen, J. Trowsdale, and N.T. Young, Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes. European Journal of Immunology, 2009. 39(11): p. 3195-3206.
36. Gerhardt, T. and K. Ley, Monocyte trafficking across the vessel wall. Cardiovascular Research, 2015. 107(3): p. 321-30.
37. SAVILL, J., Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. Journal of Clinical Investigation, 1992. 90.
38. Febbraio, M., D.P. Hajjar, and R.L. Silverstein, CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. Journal of Clinical Investigation, 2001. 108(6): p. 785-791.
39. Greenwalt, D.E., R.H. Lipsky, C.F. Ockenhouse, H. Ikeda, and G.A. Jamieson, Membrane Glycoprotein CD36: A Review of Its Roles in Adherence, Signal Transduction, and Transfusion Medicine. Blood, 1992. 80(5): p. 1105-1115.
40. Furukawa-Hibi, Y., Y. Kobayashi, C. Chen, and N. Motoyama,FOXO Transcription Factors in Cell-Cycle Regulation and the Response to Oxidative Stress. Antioxid Redox Signal, 2005. 7(5-6): p. 752-760.
41. Huang, H. and D.J. Tindall, FOXO factors: a matter of life and death. Future Oncology, 2006. 2(1): p. 83-89.
42. Burgering, B.M.T. and G.J.P.L. Kops, Cell cycle and death control: long live Forkheads. Trends in Biochemical Sciences, 2002. 27(7): p. 352-360.
43. Woods, Y.L. and G. Rena, Effect of multiple phosphorylation events on the transcription factors FKHR, FKHRL1 and AFX. Biochemical Society transactions, 2002. 30(4): p. 391.
44. G J, K., Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature, 1999. 6728(398).
45. Yang, J., ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nature cell biology, 2008. 2(10).
46. M H, C., Regulation of cell death protease caspase-9 by phosphorylation. Science (New York, N.Y.), 1998. 5392(282).
47. Zhang, X., N. Tang, T.J. Hadden, and A.K. Rishi, Akt, FoxO and regulation of apoptosis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011. 1813(11): p. 1978-1986.
48. Brunet, A., A. Bonni, M.J. Zigmond, M.Z. Lin, P. Juo, L.S. Hu, M.J. Anderson, K.C. Arden, J. Blenis, et al., Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor. Cell, 1999. 96(6): p. 857-868.